Treatment Responses, Toxicity, and Survival in Patients with Classical Hodgkin Lymphoma Aged ≥50 Years: A Single-Center Experience Over Two Decades

INTRODUCTION: The aim of this study was to evaluate treatment responses, toxicity, and survival among cHL patients aged ≥50 years. METHODS: We retrospectively identified all newly diagnosed cHL patients and only included cases who were ≥50 years old at the time of diagnosis and with data available b...

Descripción completa

Detalles Bibliográficos
Autores principales: Çokgezer, Simay, Elverdi, Tuğrul, Salihoğlu, Ayşe, Ar, Muhlis Cem, Öngören, Şeniz, Başlar, Zafer, Eşkazan, Ahmet Emre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188373/
https://www.ncbi.nlm.nih.gov/pubmed/35698602
http://dx.doi.org/10.2147/CMAR.S363235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188373/
https://www.ncbi.nlm.nih.gov/pubmed/35698602
http://dx.doi.org/10.2147/CMAR.S363235

Ejemplares similares